Buccisano, F.; Palmieri, R.; Piciocchi, A.; Maurillo, L.; Del Principe, M.I.; Paterno, G.; Soddu, S.; Cerretti, R.; De Angelis, G.; Mariotti, B.;
et al. Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation. Cancers 2021, 13, 1083.
https://doi.org/10.3390/cancers13051083
AMA Style
Buccisano F, Palmieri R, Piciocchi A, Maurillo L, Del Principe MI, Paterno G, Soddu S, Cerretti R, De Angelis G, Mariotti B,
et al. Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation. Cancers. 2021; 13(5):1083.
https://doi.org/10.3390/cancers13051083
Chicago/Turabian Style
Buccisano, Francesco, Raffaele Palmieri, Alfonso Piciocchi, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Stefano Soddu, Raffaella Cerretti, Gottardo De Angelis, Benedetta Mariotti,
and et al. 2021. "Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation" Cancers 13, no. 5: 1083.
https://doi.org/10.3390/cancers13051083
APA Style
Buccisano, F., Palmieri, R., Piciocchi, A., Maurillo, L., Del Principe, M. I., Paterno, G., Soddu, S., Cerretti, R., De Angelis, G., Mariotti, B., Irno Consalvo, M. A., Conti, C., Fraboni, D., Divona, M., Ottone, T., Lavorgna, S., Panetta, P., Voso, M. T., Arcese, W.,
& Venditti, A.
(2021). Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation. Cancers, 13(5), 1083.
https://doi.org/10.3390/cancers13051083
